Brent Rutland
Chief Tech/Sci/R&D Officer bij KORU MEDICAL SYSTEMS, INC.
Profiel
Brent Rutland is currently the Vice President-Medical Affairs at KORU Medical Systems, Inc. Prior to this, he worked as the Senior Director-Health Outcomes at La Jolla Pharmaceutical Co. from 2018 to 2022.
He also served as the Senior Medical Science Liaison at Baxter International, Inc. from 2016 to 2017.
Mr. Rutland completed his undergraduate degree at Texas A&M University and holds an MBA from the University of Houston.
He also obtained a graduate degree from the University of North Carolina at Chapel Hill.
Actieve functies van Brent Rutland
| Bedrijven | Functie | Begin |
|---|---|---|
| KORU MEDICAL SYSTEMS, INC. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Brent Rutland
| Bedrijven | Functie | Einde |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | 01-10-2022 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01-07-2017 |
Opleiding van Brent Rutland
| Texas A&M University | Undergraduate Degree |
| University of Houston | Masters Business Admin |
| University of North Carolina at Chapel Hill | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| KORU MEDICAL SYSTEMS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
